226 related articles for article (PubMed ID: 37120007)
1. Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer.
Li S; Yue M; Xu H; Zhang X; Mao T; Quan M; Ma J; Wang Y; Ge W; Wang Y; Xue S; Shentu D; Cui J; Wang L
Cancer Lett; 2023 Jun; 564():216206. PubMed ID: 37120007
[TBL] [Abstract][Full Text] [Related]
2. Steroidal saponins PPI/CCRIS/PSV induce cell death in pancreatic cancer cell through GSDME-dependent pyroptosis.
Liu Y; Zhang W; Zhou H; Chen J
Biochem Biophys Res Commun; 2023 Sep; 673():51-58. PubMed ID: 37356145
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation.
Zhang CC; Li CG; Wang YF; Xu LH; He XH; Zeng QZ; Zeng CY; Mai FY; Hu B; Ouyang DY
Apoptosis; 2019 Apr; 24(3-4):312-325. PubMed ID: 30710195
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput
Liu Y; Zhang X; Zhang P; He T; Zhang W; Ma D; Li P; Chen J
Acta Pharm Sin B; 2023 Oct; 13(10):4253-4272. PubMed ID: 37799380
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin.
Wang Y; Gao W; Shi X; Ding J; Liu W; He H; Wang K; Shao F
Nature; 2017 Jul; 547(7661):99-103. PubMed ID: 28459430
[TBL] [Abstract][Full Text] [Related]
6. Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway.
Ding M; Liu J; Lv H; Zhu Y; Chen Y; Peng H; Fan S; Chen X
Front Oncol; 2023; 13():1097772. PubMed ID: 36925932
[TBL] [Abstract][Full Text] [Related]
7. The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review.
Bhat AA; Thapa R; Afzal O; Agrawal N; Almalki WH; Kazmi I; Alzarea SI; Altamimi ASA; Prasher P; Singh SK; Dua K; Gupta G
Int J Biol Macromol; 2023 Jul; 242(Pt 2):124832. PubMed ID: 37196719
[TBL] [Abstract][Full Text] [Related]
8. High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance.
Wang G; Chen J; Dai S; Zhang J; Gao Y; Yin L; Jiang K; Miao Y; Lu Z
Apoptosis; 2024 Apr; 29(3-4):344-356. PubMed ID: 37848674
[TBL] [Abstract][Full Text] [Related]
9. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.
Xu D; Cobb MG; Gavilano L; Witherspoon SM; Williams D; White CD; Taverna P; Bednarski BK; Kim HJ; Baldwin AS; Baines AT
Cancer Biol Ther; 2013 Jun; 14(6):492-501. PubMed ID: 23760491
[TBL] [Abstract][Full Text] [Related]
11. MACC1 and Gasdermin-E (GSDME) regulate the resistance of colorectal cancer cells to irinotecan.
Cheng MZ; Yang BB; Zhan ZT; Lin SM; Fang ZP; Gao Y; Zhou WJ
Biochem Biophys Res Commun; 2023 Sep; 671():236-245. PubMed ID: 37307707
[TBL] [Abstract][Full Text] [Related]
12. The molecular mechanism and evolutionary divergence of caspase 3/7-regulated gasdermin E activation.
Xu H; Yuan Z; Qin K; Jiang S; Sun L
Elife; 2024 Mar; 12():. PubMed ID: 38489483
[TBL] [Abstract][Full Text] [Related]
13. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.
Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E
Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235
[TBL] [Abstract][Full Text] [Related]
14. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
[TBL] [Abstract][Full Text] [Related]
15. Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity.
Shen X; Wang H; Weng C; Jiang H; Chen J
Cell Death Dis; 2021 Feb; 12(2):186. PubMed ID: 33589596
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.
Mikamori M; Yamada D; Eguchi H; Hasegawa S; Kishimoto T; Tomimaru Y; Asaoka T; Noda T; Wada H; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Mori M; Doki Y
Sci Rep; 2017 Feb; 7():42339. PubMed ID: 28198398
[TBL] [Abstract][Full Text] [Related]
17. SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.
Zhang X; Zhao P; Wang C; Xin B
Biochem Biophys Res Commun; 2019 Mar; 510(4):508-514. PubMed ID: 30737032
[TBL] [Abstract][Full Text] [Related]
18. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.
Wang YH; Sui YN; Yan K; Wang LS; Wang F; Zhou JH
Oncol Rep; 2015 Apr; 33(4):1699-706. PubMed ID: 25647019
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod-like receptor family pyrin domain-containing 3/caspase-1/Gasdermin E mediated pyroptosis pathway.
Xu PP; Wu J; Zhang J; Yu TY; Wang YB
Chem Biol Drug Des; 2024 Jan; 103(1):e14325. PubMed ID: 37907334
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of gasdermin by apoptotic caspases triggers pyroptosis restricting bacterial colonization in Hydra.
Li S; Lu X; Lin X; Zhang Y; Liu Q; Chen S
Dev Comp Immunol; 2024 Jun; 155():105139. PubMed ID: 38325499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
